Compare TPCS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TPCS | CRIS |
|---|---|---|
| Founded | 1956 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.1M | 20.6M |
| IPO Year | 2008 | 2000 |
| Metric | TPCS | CRIS |
|---|---|---|
| Price | $5.73 | $1.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 52.3K | ★ 267.6K |
| Earning Date | 02-17-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 41.38 | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $31,644,000.00 | $9,898,000.00 |
| Revenue This Year | N/A | $27.10 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $2.88 | $0.18 |
| 52 Week High | $6.31 | $6.74 |
| Indicator | TPCS | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 63.51 | 28.49 |
| Support Level | $4.41 | $1.54 |
| Resistance Level | $6.31 | $5.55 |
| Average True Range (ATR) | 0.27 | 0.35 |
| MACD | 0.03 | -0.16 |
| Stochastic Oscillator | 63.98 | 3.16 |
Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.